Recent Content
- Implementing multi-level network meta-regression for time-to-event outcomes: A case study in relapsed refractory multiple myeloma
- Recent advances in the treatment and prevention of peripheral neuropathy after multiple myeloma treatment
- Results of Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma(MM) and Renal Impairment: A Retrospective Single-Center Study
- Seven-year Follow-up of India’s First Sequential Hematopoietic Stem Cell and Kidney Transplant for Multiple Myeloma
- Selenoprotein W engages in overactive osteoclast differentiation in multiple myeloma
- Therapeutic potential of third-generation chimeric antigen receptor T cells targeting B cell maturation antigen for treating multiple myeloma
- Role of Immune Cells and Immunotherapy in Multiple Myeloma
- Efficacy and Safety of Anti-CD38 Monoclonal Antibodies in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Randomized Clinical Trials
- Minimal Residual Disease-Adapted Therapy in Multiple Myeloma: Current Evidence and Opinions
- Comprehensive evaluation of genetic and acquired thrombophilia markers for an individualized prediction of clinical thrombosis in patients with lymphoma and multiple myeloma